HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

faldaprevir

inhibits hepatitis C virus NS3 protease
Also Known As:
BI 201335; BI-201335; BI201335; N-((cyclopentyloxy)carbonyl)-3-methylvalyl-4-((8-bromo-7-methoxy-2-(2-((2-methylpropanoyl)amino)-1,3-thiazol-4-yl)quinolin-4-yl)oxy)-N-(1-carboxy-2-ethenylcyclopropyl)prolinamide
Networked: 35 relevant articles (9 outcomes, 13 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Stern, Jerry O: 17 articles (03/2017 - 06/2011)
2. Asselah, Tarik: 12 articles (05/2016 - 12/2011)
3. Kukolj, George: 10 articles (01/2016 - 11/2010)
4. Zeuzem, Stefan: 9 articles (08/2016 - 12/2011)
5. Mensa, Federico J: 7 articles (08/2016 - 01/2013)
6. Bourlière, Marc: 7 articles (05/2016 - 06/2011)
7. Omata, Masao: 6 articles (03/2017 - 01/2014)
8. Scherer, Joseph: 6 articles (03/2017 - 06/2013)
9. Buti, Maria: 6 articles (08/2016 - 08/2013)
10. Böcher, Wulf O: 6 articles (05/2016 - 01/2013)

Related Diseases

1. Infections
2. Chronic Hepatitis C
3. Virus Diseases (Viral Diseases)
4. Hyperbilirubinemia
5. Hepatitis C

Related Drugs and Biologics

1. Ribavirin (Virazole)
2. deleobuvir
3. Interferons
4. Protease Inhibitors (Protease Inhibitor)
5. Simeprevir
6. Sofosbuvir
7. Nucleosides
8. peginterferon alfa-2a (Pegasys)
9. sofosbuvir drug combination ledipasvir
10. Antiviral Agents (Antivirals)

Related Therapies and Procedures

1. Therapeutics
2. Oral Administration